News
Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma ...
This article covers key health news including Primary Health Properties securing a takeover bid for Assura, Novo Nordisk's ...
3h
India Today on MSNStudy links weight-loss drugs to serious eye conditions and vision loss
Weight-loss drugs Mounjaro and Wegovy gain popularity among Indian diabetes patients. New research highlights rare but ...
18hon MSN
NHS pharmacy rollout of Wegovy and Mounjaro can get patients 'beach body ready', Minister suggests
Peter Kyle said he wants the likes of Wegovy and Mounjaro to be 'widely used' and made 'available to everyone from every ...
Danone is launching Oikos Fusion, a dairy-based drink targeting U.S. consumers using weight loss medications like Wegovy.
More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...
17h
India Today on MSNFrom Rs 30,000 to Rs 3,000, India's weight-loss game is changing. What's the catch?
With anti-obesity drugs like semaglutide set to drop in price from a staggering Rs 30,000 to just Rs 3,000 per month, ...
A new study has revealed what could be happening to your muscles after taking Ozempic, though clinical trials are needed to test on humans ...
FAT jabs could be made available over the counter at pharmacies without the need for a GP to get involved. It is one idea ...
ACROSS the UK, waistlines are shrinking – and it’s not down to willpower alone. While Ozempic-like weight-loss jabs have been hailed as a breakthrough in helping tackle Britain’s obesity ...
StockStory.org on MSN11h
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today
What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 3.6% in the afternoon session after the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results